Metropolitan Life Insurance Company (MetLife)’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-14,469
| Closed | -$1.97M | – | 2599 |
|
|
2020
Q3 | $1.97M | Sell |
14,469
-593
| -4% | -$63K | 0.03% | 418 |
|
|
2020
Q2 | $1.46M | Buy |
15,062
+1,504
| +11% | +$125K | 0.03% | 539 |
|
|
2020
Q1 | $636K | Sell |
13,558
-713
| -5% | -$45.7K | 0.01% | 926 |
|
|
2019
Q4 | $1.04M | Sell |
14,271
-254
| -2% | -$15.4K | 0.02% | 878 |
|
|
2019
Q3 | $757K | Buy |
14,525
+2,785
| +24% | +$148K | 0.01% | 1024 |
|
|
2019
Q2 | $589K | Buy |
11,740
+784
| +7% | +$38.2K | 0.01% | 1204 |
|
|
2019
Q1 | $570K | Sell |
10,956
-306
| -3% | -$14.1K | 0.01% | 1217 |
|
|
2018
Q4 | $550K | Buy |
11,262
+286
| +3% | +$15.7K | 0.01% | 1136 |
|
|
2018
Q3 | $716K | Buy |
10,976
+926
| +9% | +$54.5K | 0.01% | 1120 |
|
|
2018
Q2 | $499K | Buy |
10,050
+3,466
| +53% | +$168K | 0.01% | 1311 |
|
|
2018
Q1 | $321K | Hold |
6,584
| – | – | ﹤0.01% | 1568 |
|
|
2017
Q4 | $277K | Sell |
6,584
-6,643
| -50% | -$256K | ﹤0.01% | 1684 |
|
|
2017
Q3 | $567K | Hold |
13,227
| – | – | ﹤0.01% | 1601 |
|
|
2017
Q2 | $173K | Buy |
+13,227
| New | +$174K | ﹤0.01% | 2421 |
|
|
2016
Q4 | – | Sell |
-9,724
| Closed | -$159K | – | 2656 |
|
|
2016
Q3 | $159K | Buy |
+9,724
| New | +$176K | ﹤0.01% | 2469 |
|
Metropolitan Life Insurance Company (MetLife)'s MYOK Position: Q4 2020 in Review
Metropolitan Life Insurance Company (MetLife) sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 14,469 shares — an estimated $1.97M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in MYOK in Q3 2016 and held it in 15 quarters. The position peaked at $1.97M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Metropolitan Life Insurance Company (MetLife) reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 14,469 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.97M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 15 quarters.
- Metropolitan Life Insurance Company (MetLife)'s MyoKardia, Inc. Common Stock position peaked at $1.97M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2020, filed 16 Feb 2021.